HUP0203884A2 - Kristályos oximinoalkánsav-származékok és cukorbaj elleni alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények - Google Patents
Kristályos oximinoalkánsav-származékok és cukorbaj elleni alkalmazásuk és ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0203884A2 HUP0203884A2 HU0203884A HUP0203884A HUP0203884A2 HU P0203884 A2 HUP0203884 A2 HU P0203884A2 HU 0203884 A HU0203884 A HU 0203884A HU P0203884 A HUP0203884 A HU P0203884A HU P0203884 A2 HUP0203884 A2 HU P0203884A2
- Authority
- HU
- Hungary
- Prior art keywords
- crystals
- antidiabetics
- pharmaceutical compositions
- compositions containing
- acid derivative
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 239000013078 crystal Substances 0.000 title abstract 2
- 230000003178 anti-diabetic effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- ULVDFHLHKNJICZ-QCWLDUFUSA-N (4e)-4-[[4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]phenyl]methoxyimino]-4-phenylbutanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1COC(C=C1)=CC=C1CO\N=C(/CCC(O)=O)C1=CC=CC=C1 ULVDFHLHKNJICZ-QCWLDUFUSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- 238000002844 melting Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000004492 retinoid derivatives Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A találmány cukorbaj ellen hatásos kristályos oximino-alkánsav-származékokra, az ilyen kristályokat tartalmazógyógyszerkészítményekre és retinoiddal kapcsolatos receptorokműködését szabályozó szerekre vonatkozik. Közelebbről a találmánytárgya a (III') képletű (E)-4-[4-(5-metil-2-fenil-4-oxazolilmetoxi)benziloxiimino]-4-fenilbutánsav olyan kristályosformája, amelynek az olvadáspontja nem esik 126 °C és 127 °C közé. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30834699 | 1999-10-29 | ||
PCT/JP2000/007482 WO2001032637A1 (en) | 1999-10-29 | 2000-10-26 | Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0203884A2 true HUP0203884A2 (hu) | 2003-03-28 |
HUP0203884A3 HUP0203884A3 (en) | 2005-01-28 |
Family
ID=17979966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0203884A HUP0203884A3 (en) | 1999-10-29 | 2000-10-26 | Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics and pharmaceutical compositions containing them |
Country Status (19)
Country | Link |
---|---|
US (1) | US6777435B1 (hu) |
EP (1) | EP1224178B1 (hu) |
KR (1) | KR100433885B1 (hu) |
CN (1) | CN1407975A (hu) |
AR (1) | AR031078A1 (hu) |
AT (1) | ATE243684T1 (hu) |
AU (1) | AU7958100A (hu) |
CA (1) | CA2388200A1 (hu) |
CL (1) | CL2000002938A1 (hu) |
CO (1) | CO5261530A1 (hu) |
DE (1) | DE60003577T2 (hu) |
HK (1) | HK1044536A1 (hu) |
HU (1) | HUP0203884A3 (hu) |
MY (1) | MY135840A (hu) |
NO (1) | NO20022007L (hu) |
PE (1) | PE20010761A1 (hu) |
PL (1) | PL364171A1 (hu) |
TW (1) | TW558554B (hu) |
WO (1) | WO2001032637A1 (hu) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030134884A1 (en) * | 2000-03-28 | 2003-07-17 | Masatoshi Hazama | Neovascularization inhibitors |
CA2442917C (en) | 2001-04-04 | 2011-02-01 | Ortho-Mcneil Pharmaceutical, Inc. | Combination therapy comprising glucose reabsorption inhibitors and ppar modulators |
CN100384430C (zh) * | 2001-04-04 | 2008-04-30 | 奥索-麦克尼尔药品公司 | 含有葡萄糖重吸收抑制剂和维生素a类-x受体调节剂的联合治疗 |
EP1400529A4 (en) | 2001-05-30 | 2007-12-19 | Kissei Pharmaceutical | GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL AND INTERMEDIARY USE THEREOF |
TWI327462B (en) * | 2002-01-18 | 2010-07-21 | Sumitomo Chemical Co | Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same |
AU2003242396A1 (en) * | 2002-05-24 | 2003-12-12 | Takeda Pharmaceutical Company Limited | Insulin resistance improving agents |
US7888346B2 (en) * | 2004-09-24 | 2011-02-15 | Universtiy of Maryland, Baltimore | Method of treating organophosphorous poisoning |
US9132135B2 (en) * | 2004-09-24 | 2015-09-15 | University Of Maryland, Baltimore | Method of treating organophosphorous poisoning |
EP1937297A2 (en) * | 2005-09-08 | 2008-07-02 | Gastrotech Pharma A/S | Use of a glp-1 molecule for treatment of biliary dyskinesia and/or biliary pain/discomfort |
TW201138843A (en) | 2009-12-18 | 2011-11-16 | Colgate Palmolive Co | Biguanide preservation of precipitated calcium carbonate |
CN106211757B (zh) * | 2014-01-17 | 2022-06-07 | 康奈尔大学 | 使用维甲酸受体激动剂治疗代谢综合征相关病况的方法 |
US11191755B2 (en) | 2014-01-17 | 2021-12-07 | Cornell University | Compositions and methods for providing cardioprotective effects |
WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
KR102281228B1 (ko) | 2019-09-03 | 2021-07-22 | 신창수 | 과수나무의 가지지지용 파이프클램프 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU766831B2 (en) * | 1998-05-11 | 2003-10-23 | Takeda Pharmaceutical Company Limited | Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
WO2001032608A1 (fr) * | 1999-10-29 | 2001-05-10 | Takeda Chemical Industries, Ltd. | Procédé de préparation de dérivés d'acide oxyminoalcanoïque |
-
2000
- 2000-10-23 AR ARP000105570A patent/AR031078A1/es unknown
- 2000-10-23 TW TW089122215A patent/TW558554B/zh active
- 2000-10-24 MY MYPI20005001A patent/MY135840A/en unknown
- 2000-10-26 EP EP00970081A patent/EP1224178B1/en not_active Expired - Lifetime
- 2000-10-26 HU HU0203884A patent/HUP0203884A3/hu unknown
- 2000-10-26 CO CO00081698A patent/CO5261530A1/es not_active Application Discontinuation
- 2000-10-26 KR KR10-2001-7011003A patent/KR100433885B1/ko not_active IP Right Cessation
- 2000-10-26 PL PL00364171A patent/PL364171A1/xx not_active Application Discontinuation
- 2000-10-26 AT AT00970081T patent/ATE243684T1/de not_active IP Right Cessation
- 2000-10-26 PE PE2000001148A patent/PE20010761A1/es not_active Application Discontinuation
- 2000-10-26 US US10/111,479 patent/US6777435B1/en not_active Expired - Fee Related
- 2000-10-26 CN CN00816789A patent/CN1407975A/zh active Pending
- 2000-10-26 DE DE60003577T patent/DE60003577T2/de not_active Expired - Fee Related
- 2000-10-26 AU AU79581/00A patent/AU7958100A/en not_active Abandoned
- 2000-10-26 WO PCT/JP2000/007482 patent/WO2001032637A1/en active IP Right Grant
- 2000-10-26 CA CA002388200A patent/CA2388200A1/en not_active Abandoned
- 2000-10-26 CL CL2000002938A patent/CL2000002938A1/es unknown
-
2002
- 2002-04-26 NO NO20022007A patent/NO20022007L/no not_active Application Discontinuation
- 2002-08-21 HK HK02106108A patent/HK1044536A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20010102429A (ko) | 2001-11-15 |
CO5261530A1 (es) | 2003-03-31 |
KR100433885B1 (ko) | 2004-06-04 |
DE60003577D1 (de) | 2003-07-31 |
MY135840A (en) | 2008-07-31 |
EP1224178B1 (en) | 2003-06-25 |
US6777435B1 (en) | 2004-08-17 |
WO2001032637A1 (en) | 2001-05-10 |
AU7958100A (en) | 2001-05-14 |
CA2388200A1 (en) | 2001-05-21 |
NO20022007L (no) | 2002-06-24 |
EP1224178A1 (en) | 2002-07-24 |
TW558554B (en) | 2003-10-21 |
ATE243684T1 (de) | 2003-07-15 |
PE20010761A1 (es) | 2001-08-01 |
PL364171A1 (en) | 2004-12-13 |
DE60003577T2 (de) | 2004-04-29 |
CL2000002938A1 (es) | 2009-05-15 |
HUP0203884A3 (en) | 2005-01-28 |
AR031078A1 (es) | 2003-09-10 |
HK1044536A1 (en) | 2002-10-25 |
NO20022007D0 (no) | 2002-04-26 |
CN1407975A (zh) | 2003-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0402022A2 (hu) | Szubsztituált fenil-propionsav-származékok mint a humán peroxiszóma proliferátor-aktivált receptor alfa (PPAR) agonistái és ezeket tartalmazó gyógyszerkészítmények | |
EE200300403A (et) | N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina | |
HUP0102102A2 (hu) | Pirazolinszármazékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HUP0402503A2 (hu) | Pirrolidinonszármazékok és a vegyületeket tartalmazó gyógyászati készítmények | |
NO20042596L (no) | Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1 | |
HUP0203884A2 (hu) | Kristályos oximinoalkánsav-származékok és cukorbaj elleni alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
HUP0400710A2 (hu) | Tioéter helyettesítővel helyettesített imidazokinolinszármazékok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
TR200101961T2 (tr) | 1,2-halkalı kinolin türevleri | |
NO963053D0 (no) | Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav | |
SE8804629D0 (sv) | New therapeutically active compounds | |
DK1487829T3 (da) | Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte | |
HUP9603237A2 (hu) | (R)-(-)-2-{N-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzizotiazol-2-il)-butil]-amino-metil}-kromán kristályos hidrokloridja, eljárás előállítására és a vegyületeket tartalmazó gyógyszerkészítmények | |
HUP0303043A2 (hu) | Orrgyógyászatilag aktív vegyületek | |
ATE321543T1 (de) | Pharmazeutische zusammensetzungen mit hydroximsäurederivaten | |
ATE316962T1 (de) | Pyrimidin-derivate als selective inhibitoren von cox-2 | |
NO972623D0 (no) | Framasöytisk blanding omfattende lamotrigin | |
DE60220055D1 (de) | 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden | |
HUP9802897A2 (hu) | Optikailag aktív piridil-4H-1,2,4-oxadiazin-származék, annak alkalmazása vaszkuláris betegségek kezelésére, valamint ilyen származékot hatóanyagként tartalmazó gyógyászati készítmény | |
AU5879798A (en) | Agents inhibiting progress of pterygium and postoperative recurrence of the same | |
ATE40987T1 (de) | Acetylenische phenoxypropanolderivate und pharmazeutische zusammensetzungen fuer die behandlung von bluthochdruck. | |
HUP0400117A2 (hu) | A 2-metil-2-[4-({[4-metil-2-(4-trifluormetil-fenil)-tiazol-5-karbonil]-amino}-metil)-fenoxi]-propionsav polimorf formái, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
HUP0302880A2 (hu) | Egy ciklusos depszipeptid javított aktivitással rendelkező kristályos formáját tartalmazó gyógyászati készítmények | |
HUP0004701A2 (hu) | Új dezloratadin sók, az ezeket tartalmazó gyógyászati készítmények és eljárás azok előállítására | |
HUP0302255A2 (hu) | Szulfonamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HUP0202647A2 (hu) | Új arilalkanoilszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |